Retina: Clinical Trials

3 trials for Retina, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow Retina: new trials by email Literature Review of Retina trials Research Report on Retina

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Extension, Carbidopa-levodopa in Neovascular Age-related Macular Degeneration (AMD)
carbidopa-levodopa 25-100 mg - Macula; Degeneration, Retina
Phase 2CompletedSnyder, Robert W., M.D., Ph.D., P.C.352017-08-012025-09-12
Effects of Moxaverine and Placebo on Ocular Blood Flow
Moxaverine, Moxaverin 150mg, NaCl - Regional Blood Flow, Ocular Physiology
Phase 2CompletedMedical University of Vienna162007-03-012008-07-03
The Relationship Between Stage of Diabetic Retinopathy and Retinal Blood Flow in Patients With IDDM During Euglycemic Clamp
Insulin, Glucose - Diabetes Mellitus, Type 1, Insulin
Phase 2CompletedMedical University of Vienna641999-03-012008-12-23

Narrower conditions

Diabetes Mellitus, Type 1 (1)  ·  Insulin Resistance (1)

Broader conditions

Autoimmune Diseases (1)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Immune System Diseases (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Glucose (1)  ·  Insulin (1)  ·  carbidopa, levodopa drug combination (1)  ·  moxaverine (1)

Sponsors

Medical University of Vienna (2)  ·  Snyder, Robert W., M.D., Ph.D., P.C. (1)

Countries

Austria (2)  ·  United States (1)

Top investigators

Hans-Georg Eichler, MD (1)  ·  Michael Wolzt, MD (1)  ·  Robert W Snyder, MD, PhD (1)